AVITA Medical, Inc. (RCEL) NASDAQ

5.25

+0.14(+2.74%)

Updated at October 01 04:00PM

Currency In USD

AVITA Medical, Inc.

Address

28159 Avenue Stanford

Valencia, CA 91355

United States of America

Phone

661 367 9170

Sector

Healthcare

Industry

Medical - Devices

Employees

260

First IPO Date

May 14, 2012

Key Executives

NameTitlePayYear Born
Mr. James M. CorbettChief Executive Officer, President & Executive Director1.16M1958
Mr. David O'TooleChief Financial Officer708,8621959
Ms. Nicole Linda KelseyChief Legal & Compliance Officer and Corporate Secretary731,9651967
Dr. Niraj Doshi J.D., P.M.P., Ph.D.Senior Vice President of Product Development & Program Management0N/A
Ms. Jessica EkebergDirector of Investor Relations0N/A
Mr. Ron LagerquistSenior Vice President of Quality Assurance & Regulatory Affairs0N/A
Ms. Debbie GarnerSenior Vice President of Global Marketing & Strategy0N/A
Mr. Rob HallSenior Vice President of Human Resources0N/A
David MelbyeSenior Vice President of Operations0N/A
Dr. Katie Bush Ph.D.Senior Vice President of Scientific & Medical Affairs0N/A

Description

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.